Kathmere Capital Management’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
Other funds holding RIGL
Kathmere Capital Management's RIGL Position: Q3 2026 in Review
Kathmere Capital Management opened a new position in Rigel Pharmaceuticals (RIGL) in Q3 2026: 5,657 shares worth $272K. The stake represents 0.01% of the portfolio and ranks #581 among its holdings.
170 funds tracked by Wall St. Rank hold RIGL as of Q3 2026.
- Kathmere Capital Management held 5,657 shares of Rigel Pharmaceuticals worth $272K as of Q3 2026.
- Rigel Pharmaceuticals was a new Kathmere Capital Management position in Q3 2026.
- Rigel Pharmaceuticals made up 0.01% of Kathmere Capital Management's portfolio in Q3 2026, its #581 holding.
- 170 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2026.
Based on Kathmere Capital Management's 13F filing for Q3 2026, filed 20 Oct 2026.